Skip to main content

Table 2 Demographic summary

From: EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

Demographic characteristics

Everolimus

N  =  120

Age, median (range), years

11.0 (1–47) a

Sex, n (%)

 Male

62 (51.7)

 Female

58 (48.3)

Race, n (%)

 Caucasian

116 (96.7)

 Asian

2 (1.7)

 Native American

1 (0.8)

 Other

1 (0.8)

  1. aone patient was 1 year old (protocol deviation)